# Mechanism of total saponins of Ranunculus ternatus Thunb. in treatment of breast cancer based on liquid chromatography–mass spectrometry and network analysis

**Authors:** Yuanxin Zhang, Shuo Nan, Wei Zhao, Haisheng Xie, Jinxin Miao, Mingsan Miao

PMC · DOI: 10.3389/fphar.2025.1506885 · 2025-04-25

## TL;DR

This study explores how saponins from Ranunculus ternatus may treat breast cancer by affecting specific biological pathways and proteins.

## Contribution

The study identifies the JAK2/STAT3 signaling pathway as a potential target of RT saponins in breast cancer treatment.

## Key findings

- RT saponins inhibit JAK2 and STAT3-related proteins and mRNA in breast cancer.
- RT saponins reduce tumor growth, proliferation, and migration while promoting apoptosis.
- Serum inflammatory factors like TNF-α, IL-6, and IL-10 are affected by RT saponins.

## Abstract

To explore the mechanism of total saponins of Ranunculus ternatus Thunb. (RT) in the treatment of breast cancer (BC) using liquid chromatography–mass spectrometry (LC-MS) technology and network analysis.

The metabolites of RT were detected using LC-MS. Metabolites and targets of RT and BC were identified in different databases, and potential targets and pathways were predicted using protein–protein interaction network and pathway enrichment analyses. A mouse model of BC created by cellular injection and MCF-7 cells were used as research objects for in vivo and in vitro validation experiments to study the anti-BC mechanism of RT.

A Kyoto Encyclopedia of Genes and Genomes analysis showed that the Janus kinase/signal transducer and activator of transcription signaling pathway might be associated with the anti-BC effects of RT. The in vivo and in vitro experiments showed that Total saponins from RT had a good anti-BC effect that can inhibit the expression of JAK2 and STAT3-related proteins and mRNA, affect the expression levels of serum inflammatory factors tumor necrosis factor-α, interleukin-6, and interleukin-10, inhibit tumor growth, proliferation, and migration, and promote tumor cell apoptosis.

Total saponins from RT may play a role in BC treatment by regulating the JAK2/STAT3 signaling pathway.

Experimental flow chart.

Experimental flow chart.

## Linked entities

- **Genes:** JAK2 (Janus kinase 2) [NCBI Gene 3717], STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774]
- **Proteins:** JAK2 (Janus kinase 2), STAT3 (signal transducer and activator of transcription 3), IL6 (interleukin 6), IL10 (interleukin 10)
- **Chemicals:** saponins (PubChem CID 6540709)
- **Diseases:** breast cancer (MONDO:0004989)

## Full-text entities

- **Genes:** IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, JAK2 (Janus kinase 2) [NCBI Gene 3717] {aka JTK10}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}
- **Diseases:** inflammatory (MESH:D007249), BC (MESH:D001943), tumor (MESH:D009369)
- **Chemicals:** saponins (MESH:D012503)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** MCF-7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031)

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12062126/full.md

---
Source: https://tomesphere.com/paper/PMC12062126